Cell-based therapies have grown dramatically in power and scope in recent years. Once
limited to blood and BM transplantation, these therapies now encompass tissue repair and
regeneration, metabolic support, gene replacement, and immune effector functions, with
established and investigational clinical applications in disorders affecting nearly every tissue
and organ system. The complexity and novel applications of human cells, tissues, and
cellular and tissue-based products (HCT/Ps), however, present potential risks for adverse …